ACRV – acrivon therapeutics, inc. (US:NASDAQ)

DELAYED


Volume Shares
1 Day Range
Volume Ratio
52 Week High
52 Week Low


VWAP
Today’s Volatility
20 Day Volatility
Open
Prior Close

YTD

1 Day

ACRV

SPY

QQQ

Swipe to see more

Main News & Impact Reports

Date

Time

Symbol

Headline

Impact

11/27

06:11 pm

acrv

Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Miller Mary

Low Report

Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Miller Mary

Report

11/27

06:10 pm

acrv

Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Holm-Jorgensen Rasmus

Low Report

Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Holm-Jorgensen Rasmus

Report

11/27

06:09 pm

acrv

Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Gamelin Erick

Low Report

Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Gamelin Erick

Report

11/27

06:06 pm

acrv

Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Devroe Eric

Low Report

Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Devroe Eric

Report

11/27

06:04 pm

acrv

Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Blume-Jensen Peter

Low Report

Form 4 Acrivon Therapeutics, For: Mar 01 Filed by: Blume-Jensen Peter

Report

11/25

04:30 pm

acrv

Form 4 Acrivon Therapeutics, For: Nov 21 Filed by: Blume-Jensen Peter

Low Report

Form 4 Acrivon Therapeutics, For: Nov 21 Filed by: Blume-Jensen Peter

Report

11/18

04:32 pm

acrv

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Miller Mary

Low Report

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Miller Mary

Report

11/18

04:32 pm

acrv

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Peterson Katharine

Low Report

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Peterson Katharine

Report

11/18

04:31 pm

acrv

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Holm-Jorgensen Rasmus

Low Report

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Holm-Jorgensen Rasmus

Report

11/18

04:30 pm

acrv

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Gamelin Erick

Low Report

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Gamelin Erick

Report

11/18

04:29 pm

acrv

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Devroe Eric

Low Report

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Devroe Eric

Report

11/18

04:27 pm

acrv

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Blume-Jensen Peter

Low Report

Form 4 Acrivon Therapeutics, For: Nov 14 Filed by: Blume-Jensen Peter

Report

11/13

07:06 am

acrv

Form 10-Q Acrivon Therapeutics, For: Sep 30

Medium Report

Form 10-Q Acrivon Therapeutics, For: Sep 30

Report

11/13

07:00 am

acrv

Form 8-K Acrivon Therapeutics, For: Nov 13

Medium Report

Form 8-K Acrivon Therapeutics, For: Nov 13

Report

10/21

04:23 pm

acrv

Form 4 Acrivon Therapeutics, For: Oct 17 Filed by: Miller Mary

Neutral Report

Form 4 Acrivon Therapeutics, For: Oct 17 Filed by: Miller Mary

Report

10/11

08:00 am

acrv

Form 8-K Acrivon Therapeutics, For: Oct 11

Low Report

Form 8-K Acrivon Therapeutics, For: Oct 11

Report

10/3

06:49 pm

acrv

Form 4 Acrivon Therapeutics, For: Oct 01 Filed by: Miller Mary

Low Report

Form 4 Acrivon Therapeutics, For: Oct 01 Filed by: Miller Mary

Report

In short, News Quantified specializes in matching financial news with market data. We've analyzed 10s of millions of news events and know exactly which ones have an outsized impact on stock prices. So every single time a news item is released we know exactly what the average effect will be on a particular stock.